Product fact sheet
MitoPRO 300X
MitoPRO 300X is a compact six-wavelength panel with 60 LED lenses / 120 chips, 125 W listed consumption, app-enabled controls and a 7 lb listed weight.
A compact six-wavelength panel with Bluetooth/app controls. Homeapotherapy has verified the current manufacturer manual but has not independently measured optical or electrical performance.
compact targeted-use format, buyers comparing wavelength and control specifications
anyone requiring Homeapotherapy hands-on measurements, buyers who need independently verified optical output before purchase
Key tradeoff: The documentation is relatively detailed, but performance figures remain manufacturer-supplied unless separately verified.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
Hardware record and source discrepancy
Mito publishes the 300X as the smallest panel in its MitoPRO X range. The current product page lists six peak wavelengths—590, 630, 660, 810, 830 and 850 nm—plus 60 LED lenses / 120 chips, 125 W power consumption and a 7 lb listed weight.
The January 2026 manufacturer manual provides a separate primary-document check on operating parameters. Its parameter table identifies the MitoPRO 300X / 750X / 1500X family, lists the same six nominal peaks with ±10 nm tolerances, IP21 ingress protection, adjustable operating modes, and 300X dimensions of approximately 13 × 10 × 3 inches in that manual. The product page lists panel dimensions slightly differently. The discrepancy should remain attached to the source instead of being silently reconciled.
Manufacturer-only performance claims
Mito publishes irradiance figures and device/certification language on its sales pages. Those statements remain manufacturer-supplied unless the linked document itself is an independent laboratory or regulatory record. No independent common-protocol optical measurement is included in the current record.
Comparison points
The factual comparison points are compact footprint, six published wavelength bands, controls/app support, power consumption, included tabletop setup, warranty/return terms, and the exact status of any electrical or regulatory documentation. The 125 W consumption figure should not be compared with nominal LED wattage or with unlike irradiance measurements.
Technical specifications
Published specs and what they mean
Physical
- Dimensions
- 13 × 10 × 3 in Basis: Manufacturer manual MitoPRO X January 2026 user manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
- Weight
- 7 lb gross Basis: Manufacturer manual Manufacturer manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
Optical
- Wavelengths
- 590 / 630 / 660 / 810 / 830 / 850 nm (±10 nm) Basis: Manufacturer manual Manufacturer manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
Electrical
- Electrical protection
- Class II (no applied part); Risk Group 1 Basis: Manufacturer manual Manufacturer manual parameter table; this is not a clinical efficacy statement. Source: MitoPRO X User Manual — January 2026 (PDF)
Controls
- Running modes
- M1 red+NIR; M2 red; M3 NIR Basis: Manufacturer manual Manufacturer manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
- Timer ranges
- M1 1–20 min; M2 1–20 min; M3 1–10 min Basis: Manufacturer manual Mode-specific adjustable time ranges in the January 2026 manual. Source: MitoPRO X User Manual — January 2026 (PDF)
- Pulse mode
- M1/M3 optional infrared 10 Hz pulse; M2 no pulse Basis: Manufacturer manual Manufacturer manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
Environment
- Ingress protection
- IP21 Basis: Manufacturer manual Manufacturer manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
- Operating temperature
- 0°C to 40°C Basis: Manufacturer manual Manufacturer manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
- Operating relative humidity
- ≤80% Basis: Manufacturer manual Manufacturer manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
- Operating atmospheric pressure
- 700–1060 hPa Basis: Manufacturer manual Manufacturer manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
- Storage temperature
- -20°C to 55°C Basis: Manufacturer manual Manufacturer manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
- Storage relative humidity
- ≤85% Basis: Manufacturer manual Manufacturer manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
- Storage atmospheric pressure
- 700–1060 hPa Basis: Manufacturer manual Manufacturer manual parameter table. Source: MitoPRO X User Manual — January 2026 (PDF)
What the current record does not establish
- No Homeapotherapy or third-party common-protocol irradiance measurement is normalized for this device.
- No directly comparable electrical input measurement is normalized under the current device-spec key definitions.
- No product-specific regulatory clearance identifier has been independently verified in the normalized record.
A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Dose and irradiance context
What the output number means over time
Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.
No comparable independent average irradiance is normalized
This device may have a manufacturer-published irradiance claim, but Homeapotherapy does not calculate time-to-fluence from that number unless the current record contains a sufficiently defined independent area-average measurement. This avoids presenting unlike measurement methods as interchangeable.
What this calculation still cannot tell you
- whether this is an effective dose for any condition;
- how irradiance changes at a different distance or across curved anatomy;
- how much energy reaches tissue below the surface;
- whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
- whether peak irradiance would produce the same area exposure as the average value shown here.
Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.
Clinical evidence context
Where these wavelengths overlap with human research
Published device wavelengths: 590 / 630 / 660 / 810 / 830 / 850 nm (±10 nm).
This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.
Research areas worth checking
- Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
- Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
- Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
- Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
- Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
- Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
- See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.
Do not infer from wavelength overlap
- that this device is clinically proven for the linked condition;
- that more wavelengths are better;
- that the highest published irradiance is the best dose;
- that an open wound should be treated with a consumer device without appropriate wound assessment.
For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.
Safety first
What should make you slow down?
Follow the January 2026 manual, including its warning not to stare directly into active LEDs and its device-specific photosensitivity and contraindication guidance.
- The January 2026 manual says not to stare directly into the LEDs and includes device-specific warnings and contraindication guidance.
- Do not infer that a manufacturer registration or certification statement is broader than the underlying record or standard.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
Source trail
Primary documents and supporting evidence
- MitoPRO X Red Light Therapy PanelMito Red Light · Manufacturer · retrieved 2026-08-10
- MitoPRO X User Manual — January 2026Mito Red Light · Manufacturer manual · PDF · retrieved 2026-08-10
- Photobiomodulation (PBM) Devices - Premarket Notification [510(k)] SubmissionsU.S. Food and Drug Administration · Regulatory · retrieved 2026-08-10